by John Thomaszewicz | Blog
Silgan Closures has selected enterade as co-winner of its 2019 annual new product competition. A medical food product that Entrinsic Health CMO Joe Del Regno says has been called life-changing by those consumers using it to combat the GI side effects of chemotherapy...
by John Thomaszewicz | Blog
Background: Gastroenteropancreatic neuroendocrine tumor (GEPNET) incidence has risen 6-fold over past 3 decades. North American Neuroendocrine Tumor Society estimates that over 100,000 GEPNET patients are currently living in the United States. One of the common...
by John Thomaszewicz | Blog
The National Cancer Institute estimates that by 2025, an estimated 2.1 million people in the United States will be diagnosed with cancer every year. This is a 31-percent increase from 2012, which is due in an aging population and increase in cancer screening. The...
by John Thomaszewicz | Blog
January is Cervical Cancer Awareness Month, and enterade is proud to help raise awareness for a cancer that impacts more than 13,000 women annually. Nearly all cases of cervical cancer are caused by the human papillomavirus (HPV), a common virus that is passed from...
by John Thomaszewicz | Blog
Entrinsic Health Solutions is pleased to announce that individuals suffering from cancer treatment side-effects such as diarrhea and nausea/vomiting and chronic diarrhea can get convenient local relief by purchasing enterade® thru the following Walgreens Specialty...
by John Thomaszewicz | Blog
Each New Year provides us with a clean slate, an opportunity to rethink how we approach each day and how we can tackle goals that have seemed out of reach in the past. While obstacles exist for everyone, cancer patients also have added struggles ranging from...
by John Thomaszewicz | Blog
Managing the side effects of cancer treatment is especially hard during the holidays. Appetite loss, fatigue and nausea don’t pair well with a house full of family and friends. And for those suffering from diarrhea, big holiday dinners can be filled with more dread...
by John Thomaszewicz | Blog
Clinical Trial to Assess How enterade® Helps Retain Fluids and Reduce Diarrhea in Carcinoid Syndrome and Neuroendocrine Tumor Patients NORWOOD, Mass., December 12, 2018 – Entrinsic Health Solutions in partnership with the University of Kentucky (UK) Markey Cancer...
by John Thomaszewicz | Blog
Cancer patients undergoing treatment can experience debilitating side effects, such as dehydration and damage to the gastrointestinal (GI) system – significantly impacting their quality of life and distracting from their ultimate goal: beating cancer. Clinical cancer...
by John Thomaszewicz | Blog
University of Florida startup Entrinsic Health Solutions Inc. (EHS), an innovative health sciences company, has entered into a partnership that provides for a worldwide commercial license and supply agreement for enterade®, an amino acid-based, glucose-free,...
by John Thomaszewicz | Blog
We are widening the NET! This year, we want to highlight organizations raising awareness about neuroendocrine tumor (NET) cancer – a rare and commonly misdiagnosed form of cancer. NET cancer is frequently misdiagnosed with conditions such as: anxiety, menopause,...
by John Thomaszewicz | Blog
Get the Word Out Use the hashtags #cureNETs #worldNETcancerday #netcancer #neuroendocrine #incalliance #letstalkaboutnets #NETs Share these Key Messages about NET Cancer 5-7 out of every 100,000 are diagnosed with #netcancer each year 50% of #netcancer patients have...
